DanielSuzmanMD

Oncology • Baltimore, MD

Resident at UCSF

Join to view full profile

Dr. Suzman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Suzman's full profile

Already have an account?

Office
1650 Orleans St
# CRB1
Baltimore, MD 21287
Phone+1 410-955-8893

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2012 - 2015
University of California (San Francisco)Residency, Internal Medicine, 2009 - 2012
University of California (San Francisco)Internship, Internal Medicine, 2010 - 2011
University of Maryland School of MedicineClass of 2009

Certifications & Licensure

CA State Medical License 2010 - Present
DC State Medical License 2015 - 2026
MD State Medical License 2012 - 2023
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

FDA Approval Summary: Nadofaragene firadenovec-vncg for bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer.
Laronna Colbert, Yuxia Jia, Anurag Sharma, Jiang Hu, Zhenzhen Xu
Clinical Cancer Research. 2024-12-20
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma.
Jaleh Fallah, Brian L Heiss, Hee-Koung Joeng, Chana Weinstock, Xin Gao
Clinical Cancer Research. 2024-11-15
Equipoise Lost? Trial Conduct Challenges in an Era of Breakthrough Therapies.
Jaleh Fallah, Flora Mulkey, Mallorie H Fiero, Haley Gittleman, Chi Song
Journal of Clinical Oncology. 2024-11-10

Press Mentions

Prostate Cancer: Symptoms, Tests, and TreatmentFebruary 13th, 2018